Hepatocellular Carcinoma Sorafenib: Tumor Volume as a predictive Value for the Response to Therapies?

被引:0
|
作者
Rukavina, Marion
机构
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2014年 / 52卷 / 09期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma
    Nagahama, H
    Okada, S
    Okusaka, T
    Ishii, H
    Ikeda, M
    Nakasuka, H
    Yoshimori, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 321 - 324
  • [22] PREDICTIVE VALUE OF TUMOR MARKER ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
    Choi, Gi H.
    Kim, Myoung S.
    Kim, Soon I.
    Lee, Hyung S.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 85 - 85
  • [23] Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
    Villanueva, Augusto
    Llovet, Josep M.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1824 - 1826
  • [24] The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
    Sarpel, Umut
    Spivack, John H.
    Berger, Yaniv
    Heskel, Marina
    Aycart, Samantha N.
    Sweeney, Robert
    Edwards, Martin P.
    Labow, Daniel M.
    Kim, Edward
    [J]. HPB, 2016, 18 (05) : 411 - 418
  • [25] Genomic characteristics of hepatocellular carcinoma patients with response to sorafenib
    Yim, Sun Young
    Kang, Sang-Hee
    Lee, Young-Sun
    Lee, Yoonseok
    Lim, Ji-Hwan
    Kim, Tae Hyung
    Jung, Young Kul
    Seo, Yeon Seok
    Yim, Hyung Joon
    Yeon, Jong Eun
    Lee, Ju-Seog
    Kim, Ji Hoon
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S578 - S578
  • [26] GENOMIC CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA PATIENTS WITH RESPONSE TO SORAFENIB
    Young, Yim Sun
    Kim, Ji Hoon
    Yim, Hyung Joon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Lee, Young-Sun
    Kim, Taehyung
    Kang, Seong Hee
    Lee, Yoonseok
    Kim, Jong Su
    Jung, Chang Hee
    [J]. HEPATOLOGY, 2023, 78 : S2132 - S2133
  • [27] Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
    Augello, Giuseppa
    Arbitrio, Mariamena
    Giannitrapani, Lydia
    Scionti, Francesca
    Ciliberto, Domenico
    Staropoli, Nicoletta
    Agapito, Giuseppe
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Soresi, Maurizio
    Seidita, Aurelio
    Affronti, Marco
    Bertino, Gaetano
    Russello, Maurizio
    Di Gaudio, Francesca
    Ciriminna, Rosaria
    Spinnato, Francesca
    Verderame, Francesco
    Cervello, Melchiorre
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S568 - S568
  • [28] Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
    Hong-bo Huan
    Wan-Yee Lau
    Feng Xia
    Kuan-sheng Ma
    Ping bie
    [J]. World Journal of Gastroenterology, 2014, (39) : 14505 - 14509
  • [29] Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma
    Giannitrapani, Lydia
    Di Gaudio, Francesca
    Cervello, Melchiorre
    Scionti, Francesca
    Ciliberto, Domenico
    Staropoli, Nicoletta
    Agapito, Giuseppe
    Cannataro, Mario
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Seidita, Aurelio
    Soresi, Maurizio
    Affronti, Marco
    Bertino, Gaetano
    Russello, Maurizio
    Ciriminna, Rosaria
    Lino, Claudia
    Spinnato, Francesca
    Verderame, Francesco
    Augello, Giuseppa
    Arbitrio, Mariamena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [30] Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks
    Kanthaje, Shruthi
    Makol, Ankita
    Chakraborti, Anuradha
    [J]. HEPATOLOGY RESEARCH, 2018, 48 (01) : 5 - 14